Alpha Thalassemia Major
Phase 1 Clinical Trial: In Utero Hematopoietic Stem Cell Transplantation for ATM
UCSF Fetal Treatment Center
Dedicated to research and innovation in diagnosis and treatment
Multidisciplinary Approach
All the members of our multidisciplinary Fetal Treatment Center (FTC) team play an integral role in your care. The team includes clinicians involved in the direct care of patients as well as research fellows who are developing novel therapies in diagnosis and treatment of the fetus. Our team meets weekly to discuss your care, patient outcomes, birth results, and — equally important — to share recent research which ultimately may result in even more effective fetal interventions.
Fetal Research
Leaders in genomics and precision-based in utero diagnosis and care
Fetal Exome Sequencing
Better fetal diagnosis and treatment through next-generation gene sequencing
Fetal Heart & Brain Study
Studying how congenital heart disease affects fetal brain development
HyDROPS
A precision-based approach to care for Non-Immune Hydrops Fetalis
In Utero Enzyme Replacement Therapy
Phase 1 Clinical Trial: In Utero Enzyme Replacement Therapy (ERT) for Fetuses with Lysosomal Storage Diseases (LSDs)
RAFT Trial
Fetal intervention trial for bilateral renal agenesis and fetal renal failure
MedConnection Videos
Resources from leading medical experts from UCSF Fetal Treatment Center
In Utero Therapy for Serious Genetic Disorders: Saving and Improving Children’s Lives
Early fetal therapies have the power to change everything for babies and families affected by alpha thalassemia major or lysosomal storage diseases.
Window of Opportunity: The Potential Payoff of Early Fetal Ultrasound
Perinatologist and medical geneticist Mary E. Norton, MD, discusses the value – and clarifies the limitations – of fetal ultrasound as early as 11 weeks.
Aortic Abnormalities: How to Identify Pediatric Patients at Risk
Pediatric cardiologist Emilio Quezada, MD, discusses signs that a young patient should be evaluated for genetic syndromes associated with thoracic aorta dilation and aneurysm.
Congenital Heart Disease: The Value and Future of Fetal Screening
With CHD often discovered in low-risk pregnancies and associated with neurodevelopmental deficits, the need for more screening and advanced techniques is clear.
The Potential of Fetal MRI: Delivering Value Now and in the Future
UCSF pediatric radiology specialists address fetal MRI safety concerns and explain when to consider advanced imaging.